The 5 analysts offering 12-month price forecasts for Ocuphire Pharma Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 16.00. The median estimate represents a +616.85% increase from the last price of 2.79.
The current consensus among 5 polled investment analysts is to Buy stock in Ocuphire Pharma Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.05
Reporting Date Mar 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.